de Azevedo Diogo Freitas Cardoso, Hueb Whady, Lima Eduardo Gomes, Rezende Paulo Cury, Nomura Cesar Higa, Franchini Ramires José Antonio, Kalil Filho Roberto
Department of Clinical Cardiology, Heart Institute (InCor) University of São Paulo, São Paulo, Brazil.
Medicine (Baltimore). 2025 May 30;104(22):e42478. doi: 10.1097/MD.0000000000042478.
Cardiac biomarkers are frequently released after revascularization. Incomplete revascularization may be a potential mechanism of action. This study aimed to investigate the relationship between the completeness of revascularization, quantified by the residual SYNTAX score (rSS), and myocardial injury, infarction, and cardiac events after coronary artery bypass grafting. This study included patients with stable coronary artery disease who underwent surgery. Troponin levels, cardiac magnetic resonance, and late gadolinium enhancement were assessed before and after the procedure. The baseline SYNTAX score was determined from the angiograms, and the rSS was measured based on the operative report for each patient after the procedure. Of the 136 surgical patients studied, no significant correlations were found between the rSS and median peak troponin level (R = 0.06, P = .47). The rSS was not a predictor of myocardial infarction, as assessed by late gadolinium enhancement (odds ratio [OR] 0.96, 95% confidence interval [CI] 0.86-1.03; P = .51) and release of troponin higher than the median (OR 1.00, 95% CI 0.92-1.08; P = .93). After multivariate analysis in a model including variables, only cardiopulmonary bypass time was a significant predictor of troponin peak release, which was higher than the median (OR 1.01, 95% CI 1.002-1.019; P = .01). During the 5-year follow-up, the incomplete revascularization group had more major cardiovascular events than the complete revascularization group (rSS = 0) (P log-rank = .006, adjusted hazard ratio = 11.32; P = .001). Myocardial injury and infarction were not significantly associated with the completeness of revascularization. However, the rSS had a prognostic impact during follow-up for cardiovascular events.
心脏生物标志物常在血运重建后释放。不完全血运重建可能是一种潜在作用机制。本研究旨在探讨以残余SYNTAX评分(rSS)量化的血运重建完整性与冠状动脉旁路移植术后心肌损伤、梗死及心脏事件之间的关系。本研究纳入了接受手术的稳定型冠状动脉疾病患者。在手术前后评估肌钙蛋白水平、心脏磁共振成像及延迟钆增强。基线SYNTAX评分由血管造影确定,rSS根据术后每位患者的手术报告测量。在136例接受手术的患者中,未发现rSS与肌钙蛋白峰值中位数水平之间存在显著相关性(R = 0.06,P = 0.47)。通过延迟钆增强评估(优势比[OR] 0.96,95%置信区间[CI] 0.86 - 1.03;P = 0.51)以及肌钙蛋白释放高于中位数(OR 1.00,95% CI 0.92 - 1.08;P = 0.93),rSS并非心肌梗死的预测指标。在包含多个变量的模型中进行多因素分析后,仅体外循环时间是肌钙蛋白峰值释放高于中位数的显著预测指标(OR 1.01,95% CI 1.002 - 1.019;P = 0.01)。在5年随访期间,不完全血运重建组比完全血运重建组(rSS = 0)有更多的主要心血管事件(P对数秩检验 = 0.006,调整后风险比 = 11.32;P = 0.001)。心肌损伤和梗死与血运重建的完整性无显著关联。然而,rSS在心血管事件随访期间具有预后影响。